Cytek Biosciences, Inc.
CTKB· Nasdaq
Released Aug 10, 2022, after the close
10-Q filed Aug 10, 2022, 41 days after period end · 0000950170-22-016500
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Revenue | $40.16M | $30.41M | $19.14M |
| Net Income | -$702.00K | $2.67M | $8.11M |
| EPS Diluted | $0.00 | $0.00 | $0.06 |
Cytek Biosciences, Inc. · CIK 1831915 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.